Literature DB >> 812671

A controlled evaluation of loxitane in seventy-five adolescent schizophrenic patients.

D Pool, W Bloom, D H Mielke, J J Roniger, D M Gallant.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 812671

Source DB:  PubMed          Journal:  Curr Ther Res Clin Exp        ISSN： 0011-393X


× No keyword cloud information.
  18 in total

Review 1.  Typical neuroleptics in child and adolescent psychiatry.

Authors:  C Gillberg
Journal:  Eur Child Adolesc Psychiatry       Date:  2000       Impact factor: 4.785

Review 2.  Management of schizophrenia in children and adolescents: focus on pharmacotherapy.

Authors:  Gabriele Masi; Francesca Liboni
Journal:  Drugs       Date:  2011-01-22       Impact factor: 9.546

Review 3.  Loxapine: a review of its pharmacological properties and therapeutic efficacy as an antipsychotic agent.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-03       Impact factor: 9.546

Review 4.  Insomnia in children: when are hypnotics indicated?

Authors:  Mohammed Younus; Michael J Labellarte
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

5.  Relations between movement disorders and psychopathology under predominantly atypical antipsychotic treatment in adolescent patients with schizophrenia.

Authors:  Stefan Gebhardt; Fabian Härtling; Markus Hanke; Frank M Theisen; Richard von Georgi; Phillip Grant; Markus Mittendorf; Matthias Martin; Christian Fleischhaker; Eberhard Schulz; Helmut Remschmidt
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-09-14       Impact factor: 4.785

6.  Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patients.

Authors:  Ann E Maloney; Linmarie Sikich
Journal:  Neuropsychiatr Dis Treat       Date:  2010-11-10       Impact factor: 2.570

Review 7.  [Off-label use in child and adolescent psychiatry. An ongoing ethical, medical and legal problem].

Authors:  M Kölch; M Allroggen; J M Fegert
Journal:  Nervenarzt       Date:  2009-07       Impact factor: 1.214

Review 8.  Loxapine for schizophrenia.

Authors:  A Chakrabarti; A Bagnall; P Chue; M Fenton; V Palaniswamy; W Wong; J Xia
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17

9.  Safety of 80 antidepressants, antipsychotics, anti-attention-deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta-review of 78 adverse effects.

Authors:  Marco Solmi; Michele Fornaro; Edoardo G Ostinelli; Caroline Zangani; Giovanni Croatto; Francesco Monaco; Damir Krinitski; Paolo Fusar-Poli; Christoph U Correll
Journal:  World Psychiatry       Date:  2020-06       Impact factor: 49.548

Review 10.  Antipsychotics in early onset Schizophrenia: Systematic review and meta-analysis.

Authors:  Jorge L Armenteros; Mark Davies
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-02-09       Impact factor: 4.785
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.